Equity Analysis

Quarterly Results

    Wanbury Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524212
    INE107F01022
    6.7020953
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WANBURY
    29.69
    793.62
    EPS(TTM)
    Face Value()
    Div & Yield %:
    8.16
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales161.19131.11139.41
Other Operating Income0.000.000.00
Other Income 1.630.940.93
Total Income162.82132.05140.33
Total Expenditure 141.18120.13121.24
PBIDT21.6411.9219.09
Interest 10.157.597.46
PBDT11.494.3311.63
Depreciation3.323.293.28
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.150.000.27
Reported Profit After Tax8.021.048.08
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item8.021.048.08
EPS (Unit Curr.)2.440.322.47
EPS (Adj) (Unit Curr.)2.440.322.47
Calculated EPS (Unit Curr.)2.450.322.47
Calculated EPS (Adj) (Unit Curr.)2.450.322.47
Calculated EPS (Ann.) (Unit Curr.)9.791.279.87
Calculated EPS (Adj) (Ann.) (Unit Curr.)9.791.279.87
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity32.7632.7532.75
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)13.439.0913.69
PBDTM(%)7.133.308.34
PATM(%)4.980.795.80
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.340.312.47